Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension

Journal of Hypertension

Volumn 14, Issue 7, 1996, Pages 915-920

  Cerasola, Giovanni ^a,b   Cottone, Santina ^a   Mulé, Giuseppe ^a   Nardi, Emilio ^a   Mangano, Maria T ^a   Andronico, Giuseppe ^a   Contorno, Antonino ^a   Li Vecchi, Maurizio ^a   Galione, Pietro ^a   Renda, Fabrizio ^a   Piazza, Giuseppe ^a   Volpe, Vito ^a   Lisi, Alessandro ^a   Ferrara, Lidia ^a   Panepinto, Nicolò ^a   Riccobene, Raffaella ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

Hypertensive nephropathy; Hypertensive retinopathy; Left ventricular hypertrophy; Microalbuminuria; Target organ damage

Indexed keywords

CREATININE; RENIN;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; EYE FUNDUS; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE COMPLIANCE; HUMAN; HYPERTENSION RETINOPATHY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 8944233365     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199607000-00016     Document Type: Article

References (23)

1. Viberti GC, Hill R, Jarrett R, Mahumud U, Argyropoulos A, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982, i:1430-1432.
2. Mogensen CE: Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987, 31:673-689.
3. Mattock MB, Morrish NJ, Viberti GC, Keen H: Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992, 41:736-741.
4. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984, 310:356-360.
5. Mattock MB, Keen R, Viberti G: Coronary heart disease and urinary albumin excretion rate in type II diabetic patients. Diabetologia 1988, 31:82-87.
6. Giaconi S, Levanti C, Fommei E, Innocenti F, Seghieri G, Palla L, et al.; Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. Am J Hypertens 1989, 2:259-261.
7. Cerasola G, Cottone S, D'Ignoto G, Grasso L, Carapelle E, Mangano MT, et al.: Microalbuminuria as predictor of cardiovascular damage in essential hypertension. J Hypertens 1989, 7 (suppl 7):S332-S333.
8. Cerasola G, Cottone S, d'Ignoto G, Grasso L, Mangano MT, Andronico G, et al.: Microalbuminuria points out early renal and cardiovascular changes in essential hypertension. Rev Latina Cardiol 1992, 13:15-21.
9. Cottone S, Cerasola G: Microalbuminuria fractional clearance and early renal permselectivity changes in essential hypertension. Am J Nephrol 1992, 12:326-329.
10. Redon J, Liao Y, Lozano JV, Miralles A, Pascual JM, Cooper RS: Ambulatory blood pressure and microalbuminuria in essential hypertension: role of circadian variability. J Hypertens 1994, 12: 947-953.
11. Yudkin JS, Forre RD, Jackson CA: Microalbuminuria as a predictor of vascular disease in non-diabetic subjects. Lancet 1988, ii:531-534.
12. Pedrinelli R, Giampietro O, Carmassi F, Melillo E, Dell'Omo G, Catapano G, et al.: Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994, 344:14-14.
13. Devereux RB, Reicheck N: Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977, 55:613-618.
14. Vajani L: La superficie di regressione e la correlazione muttipla e parziale [in Italian]. In Statistica descrittiva. Edited by Vajani L. Milan: ETAS Libri Gruppo Editoriale Bompiani-Sonzogno; 1978:543.
15. Brenner B, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation and intrinsic renal disease. N Engl J Med 1982, 307:652-659.
16. Ruilope LM, Rodicio JL: Microalbuminuria in clinical practice. Kidney: a Current Survey of World Literature 1995, 4:211-216.
17. Ruilope LM, Alcazar JM, Rodicio JL: Renal consequences of arterial hypertension. J Hypertens 1992, 10 (suppl 7):S85-S90.
18. Mimran A, Ribstein J, Du Cailar G: Is microalbuminuria a marker of intrarenal vascular dysfunction in essential hypertension? Hypertension 1994, 223 (part 2):1018-1021.
19. Yudkin JS: Microalbuminuria in vascular disease. In Microalbuminuria a Marker for Organ Damage. Edited by Mogensen CE. London: Science Press; 1993:10-19.
20. Agewall S, Wikstrand J, Ljungman S, Herlitz H, Fagerberg B on behalf of the Risk Factor Intervention Study Group: Does microalbuminuria predict cardiovascular events in non diabetic men with treated hypertension? Am J Hypertens 1995, 8:337-342.
21. Agewall S, Persson B, Samuelsson O: Microalbuminuria in treated hypertensive men at high risk of coronary disease. J Hypertens 1993, 11:461-469.
22. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991, 114: 345-352.
23. Muiesan ML, Salvetti M, Rizzoni D, Castellano M, Donato F, Agabiti-Rosei E: Association of change in left ventricular mass with prognosis during long-term antlhypertensive treatment J Hypertens 1995, 13: 1091-1095.